(LEAD) Samsung Biologics Q2 net profit up 72 pct on strong sales
Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Wednesday its second-quarter net profit jumped 72 percent from a year earlier on robust sales.
Net profit reached 318 billion won (US$229.8 million) in the April-June period…